We are live on ! Find out more
NNVC icon

NanoViricides

33 hedge funds and large institutions have $1.87M invested in NanoViricides in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

8% more capital invested

Capital invested by funds: $1.74M → $1.87M (+$132K)

1.19% less ownership

Funds ownership: 9.5%8.31% (-1.2%)

11% less funds holding

Funds holding: 3733 (-4)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
33
Holders Change
-4
Holders Change %
-10.81%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
2
Closed
8
Calls
$127K
Puts
Net Calls
+$127K
Net Calls Change
+$25K

NNVC Hedge Fund Activity: Q2 2025 in Review

33 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2025, worth a combined $1.87M — up 7.6% from $1.74M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NNVC and 5 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 8 added.

The largest buyer was UBS Group, adding an estimated $153K. The largest seller was Compagnie Lombard Odier SCmA, exiting entirely with an estimated $273K sold.

  • 33 institutional investors held NanoViricides (NNVC) as of Q2 2025, down from 37 in Q1 2025.
  • Funds reported $1.87M of NanoViricides stock for Q2 2025, up 7.6% quarter-over-quarter.
  • 5 funds opened new NanoViricides positions in Q2 2025 and 8 closed out, a net change of -3 holders.
  • The largest NanoViricides buyer in Q2 2025 was UBS Group, an estimated $153K added.
  • The largest NanoViricides seller in Q2 2025 was Compagnie Lombard Odier SCmA, an estimated $273K sold.

Based on aggregated 13F filings for Q2 2025.